Fibronectin promotes tumor angiogenesis and progression of non-small-cell lung cancer by elevating WISP3 expression via FAK/MAPK/ HIF-1α axis and activating wnt signaling pathway
Fei Zhou(Tongji University), Guanghui Gao(Tongji University)
Cited by 82
Related Papers
MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
|Lung Cancer|2013|178
Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysis
|Cancer Immunology Immunotherapy|2018|99
T790M mutation is associated with better efficacy of treatment beyond progression with EGFR-TKI in advanced NSCLC patients
|Lung Cancer|2014|94
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial
|Signal Transduction and Targeted Therapy|2021|94